TSCAN THERAPEUTICS, INC. (TCRX) Net income 2020–2025
TSCAN THERAPEUTICS, INC. (TCRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$129.8MFY2025 · since FY2020: -$26.1M → -$129.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$129.8M | -1.8% |
| FY2024 | -$127.5M | -42.9% |
| FY2023 | -$89.2M | -34.7% |
| FY2022 | -$66.2M | -36.2% |
| FY2021 | -$48.6M | -86.1% |
| FY2020 | -$26.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TCRX financial trends
TCRX RevenueTCRX Net marginTCRX Gross profitTCRX Gross marginTCRX Operating incomeTCRX Operating marginTCRX Operating cash flowTCRX Free cash flowTCRX Capital expendituresTCRX Return on equityTCRX Stock buybacksTCRX Dividends paidTCRX Total assetsTCRX Total liabilitiesTCRX Shareholders’ equityTCRX overview →